Sanofi (SNY) EPS (Diluted) (2009 - 2026)
Sanofi (SNY) EPS (Diluted) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 1.71 |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 1.61 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | -0.04 |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 0.28 |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | 0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.30 |
| Mar 31, 2026 | 1.54 |
| Dec 31, 2025 | -6.28 |
| Sep 30, 2025 | 8.18 |
| Jun 30, 2025 | 3.62 |
| Mar 31, 2025 | 1.57 |
| Dec 31, 2024 | 0.42 |
| Sep 30, 2024 | 2.47 |
| Jun 30, 2024 | 0.96 |
| Mar 31, 2024 | 0.98 |
| Dec 31, 2023 | -0.48 |
| Sep 30, 2023 | 2.19 |
| Jun 30, 2023 | 1.25 |
| Mar 31, 2023 | 1.70 |
| Dec 31, 2022 | 4.27 |
| Sep 30, 2022 | 1.67 |
| Jun 30, 2022 | 1.00 |
| Mar 31, 2022 | 1.79 |
| Dec 31, 2021 | 4.61 |
| Sep 30, 2021 | 2.17 |